Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.36

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: shasta23 who wrote (20485)	5/11/1998 5:46:00 PM
From: Henry Niman	Read Replies (1) of 32384

Stefan, As I recall, LGND could take the drug (DAB-IL2 )for cancer for $20 million, which is what they are doing. However the drug also has psoriasis applications which are not owned by LLY. SRGN also has additional cancer drugs. Thus, LGND is getting LLY's share (for $20 million), SRGN (for $67 million?), and the manufacturing plant (for $8 million). Part of the $67 million and all of the $20 million to LLY are contingent on FDA approval of DAB-IL2 That's my quick take. I'll post more soon.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next